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Introduction
Multiple organ failure (MOF) remains the main problem in
intensive care because of increased morbidity, mortality and
resource use [1]. MOF can develop due to multiple causes,
such as infection, trauma or surgery, which may lead to acti-
vation of various endogenous cascades causing cellular dys-
function and death [2,3]. Surviving patients in several studies
have had higher cardiac index and oxygen delivery than
ACF = acute circulatory failure; ICU = intensive care unit; MOF = multiple organ failure; SOFA = Sequential Organ Failure Assessment; TMS =
total maximal Sequential Organ Failure Assessment.
Abstract
Introduction Hemodynamic goals in the treatment of acute circulatory failure (ACF) are controversial.
In critical care, organ failures can be assessed using Sequential Organ Failure Assessment and its
refinement, total maximal Sequential Organ Failure Assessment (TMS). We studied the associations
between resolution of ACF and hemodynamics in the early (<24 hours) phase of intensive care unit
care and their relation to TMS and mortality.
Patients and methods Eighty-three patients with ACF (defined as arterial lactate >2mmol/l and/or
base deficit >4) who had pulmonary artery catheters and stayed for longer than 24 hours in the
intensive care unit were included. Hemodynamics, oxygen transport, vasoactive drugs and TMS scores
were recorded. Normalisation of hyperlactatemia and metabolic acidosis in less than 24 hours after
admission was defined as a positive response to hemodynamic resuscitation.
Results  Fifty-two patients responded to resuscitation. Nonresponders had higher mortality than
responders (52% versus 33%, P=0.044). Hospital mortality was highest (63%) among
nonresponders who received vasoactive drugs. The TMS scores of nonresponders (median
[interquartile range], 12[9–16]) were higher than the scores of responders (10[7–12], P=0.019).
Late accumulation of TMS scores was associated with increasing mortality, and if the TMS score
increase occurred >5 days after admission then the mortality was 77%. Responders had higher mean
arterial pressure at 24hours, but it was no different between survivors and nonsurvivors. No other
hemodynamic and oxygen transport variables were associated with the success of resuscitation or
with mortality.
Conclusions Except for the mean arterial pressure at 24 hours, invasively derived hemodynamic and
oxygen transport variables are not associated with the response to resuscitation or with mortality.
Positive response to resuscitation in ACF is associated with less severe organ failures as judged by
TMS scores. Late accumulation of the TMS score predicts poor outcome.
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patients who died. This led to the rationale of supranormal
oxygen delivery, and indeed surgical and trauma patients had
better outcome if oxygen delivery was augmented by giving
fluids and inotropes [4,5]. This treatment does not uniformly
improve outcome, however, and aggressive efforts to
increase oxygen delivery may even increase mortality [6–10].
Most trials testing the effect of augmented oxygen delivery on
outcome have used the cardiac index, oxygen delivery or
mixed venous oxygen saturation as goals for hemodynamic
support [8,11]. However, the use of routine invasive monitor-
ing has recently been questioned [12]. A meta-analysis of
21 randomised controlled trials revealed that when critically ill
patients are treated early before organ failure develops, and
optimal goals and differences in oxygen transport can be
achieved, the mortality can be reduced [13].
Acute circulatory failure (ACF) can be defined in several
ways. The definition can be based on biochemical markers,
hemodynamic measurements, end-organ dysfunction or on
combinations of these. Biochemical markers of impaired
tissue perfusion are useful because they relate more to con-
sequences of hypoperfusion than to underlying hemodynamic
patterns, which can vary considerably in different groups of
patients. In critically ill patients, arterial blood lactate concen-
tration and base deficit can reflect the severity of hypoperfu-
sion and they correlate with outcome [14–17]. Therefore, by
improving tissue perfusion, as reflected by a disappearance
of hyperlactatemia and metabolic acidosis, one may assume
to improve patient outcome. However, the lactate elevation is
not always caused by hypoxia resulting from insufficient
tissue perfusion [18,19] and it can also be confounded by
factors not related to tissue perfusion [20].
Prolonged organ system failure is associated with poor prog-
nosis [21]. Attempts to characterise the severity of organ fail-
ures and to predict patient outcome has lead to the generation
of numerous scoring systems, but none of them has gained
general acceptance [22]. Recently, calculation of the total
maximal Sequential Organ Failure Assessment (TMS) score
has been proposed as a refinement of Sequential Organ
Failure Assessment (SOFA) classification [23], and it was
shown to be applicable for outcome prediction [24,25].
In the present study, we evaluate the impact of rapid resolu-
tion of ACF (as indicated by disappearance of hyperlac-
tatemia and metabolic acidosis) on the development of organ
failures (as assessed by the TMS score) and on death. We
also study the associations between hemodynamics, the res-
olution of shock and the development of organ failures.
Finally, we study the evolution of organ failures and its associ-
ation with mortality in these critically ill patients.
Patients and methods
The Ethics Committee of the Kuopio University Hospital
approved this study. Informed consent was waived because
all data were analysed retrospectively and no research-
related interventions were carried out. Emergency admit-
tances because of ACF and of patients who had pulmonary
artery catheters were identified from our clinical information
management system (Clinisoft; Datex-Ohmeda, Helsinki,
Finland) and from patient records for a period of 1 year
(between 1 August 1998 and 31 July 1999).
Only patients with an intensive care unit (ICU) length of stay
longer than 24 hours were included. ACF was defined as a
presence of metabolic acidosis (base deficit >4) and/or
hyperlactatemia (arterial lactate >2mmol/l) during the first
24 hours of ICU care. Open heart surgery patients, neurosur-
gical patients, patients younger than the age of 15, patients
treated in referring ICUs for longer than 12 hours and
patients with intoxications were excluded. For nine patients
with multiple admissions, the last admission was selected.
Treatment was withdrawn very soon after admission in two
cases because of extremely poor prognosis, and these
patients were also excluded. One patient was excluded
because of technical problems with the database. From 210
screened patients, 83 fulfilled all inclusion criteria. Treatment
of ACF was defined as successful and patients defined as
responders if both metabolic acidosis and hyperlactatemia
were not present 24 hours after admission. If hyperlactatemia
and/or metabolic acidosis were still present at this time point,
patients were defined as nonresponders. If laboratory values
for base deficit and/or lactate concentrations were not avail-
able at exactly the 24-hour time point, a linear trend of adja-
cent values was assumed and the value at 24 hours was
estimated. Patients were treated according to the clinical
practise of the unit without having consistent targets for
hemodynamic variables.
The hemodynamic and treatment profiles of each patient
were studied by reconstructing identical sets of trend curves
as in the original clinical situation using the clinical informa-
tion management system. The trend curves consisted of all
hemodynamic data, urine output, Glasgow Coma Scale
value, blood gas values, arterial lactate concentrations, pulse
oximetry readings and vasoactive drug infusions. The infu-
sion rates of vasoactive drugs were recorded if they were
necessary for the SOFA scoring. A combination of drugs
could be administered either simultaneously or in sequence.
Dobutamine and dopamine were the inotropes used most
often. Other sympathomimetic drugs used were norepineph-
rine and epinephrine. Sodium nitroprusside or nitroglycerin
was used for vasodilatation.
Continuously measured variables were stored in the database
as 2-min median values, and other variables were stored as
often as they were measured. The pulmonary artery occlusion
pressure, the cardiac output, the urine output and the
Glasgow coma scale value were measured hourly by nurses.
The oxygen delivery index was calculated using the formula:
DO2I=1.34×[hemoglobin]×SaO2×cardiac index. We also
recorded the amounts of fluids and red blood cells infusedR54
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during the first 24 hours of ICU care. Laboratory tests were
taken when clinically indicated. ICU admission causes were
divided into six diagnostic categories: cardiovascular, respira-
tory, infection, trauma, cardiac arrest and others. Sepsis was
defined according to the Consensus conference recommen-
dation [26] and, in each case, either the positive microbial
culture or the obvious source of infection was identified.
Daily SOFA scores were calculated for the entire period of
the ICU stay [23]. Missing laboratory values were interpo-
lated if adjacent values were present. If more than one value
was missing, they were not interpolated but scored as
missing and given 0 points. This was necessary only for biliru-
bin. If more than one laboratory value was available for the
same day, the worst value was chosen. To describe the
severity of organ failure, the TMS score was calculated by
summing the maximum scores of each of the six organ
systems during the whole ICU period [27,28]. The theoretical
maximum of the TMS score is thus 24. To describe the evolu-
tion of organ failure and its impact on outcome, we deter-
mined the time to peak TMS. This was defined as the ICU day
when the TMS score reached its maximum.
Statistical methods
Between-group comparisons were performed with the
Kruskal–Wallis and Mann–Whitney U tests. Proportions were
tested in 2×2 tables with the McNemar test and in
2×3 tables with the chi-square test. Yates’ correction was
used if appropriate. Data are presented as the mean (95%
confidence interval) or as the median (interquartile range)
depending on the distribution of the data. Percentages were
compared using the test of proportions. P<0.05 was consid-
ered statistically significant. Statistical procedures were
carried out using the SPSS 9.0 statistical package (SPSS
Inc., Chicago, IL, USA).
Results
The clinical data of the patients are presented in Table 1. The
ICU mortality was 33.7% and hospital mortality was 39.8%.
Twenty out of 83 patients were operated on before admission
or during the first day, and 64/83 patients were mechanically
ventilated. Sepsis was identified in 20 out of 83 patients.
Fifty-two patients (63%) responded to the treatment and the
perfusion failure subsided during the first 24 hours, while
31 patients (37%) were nonresponders with a persisting cir-
culatory failure (Table 2); there was no difference in Acute
Physiologic and Chronic Health Evaluation II scores between
these groups (P=0.1). Vasoactive treatment was given to
63 patients: 48 patients received sympathomimetic drugs,
either inotropes alone (27 patients), norepinephrine alone
(12 patients) or their combination (9 patients). Vasodilators
were given to 27 patients in order to reduce afterload; in
16 cases alone and in 11 cases with inotropic drugs. The
hospital mortality of nonresponders was higher than that of
responders (55% versus 33%, P=0.044), and it was highest
for nonresponders receiving vasoactive treatment (Table 2).
Table 1
Demographic data of the patients
Number of patients 83
Mean (range) age (years) 63.7(15–89)
Male/female 54/29
Acute Physiologic and Chronic Health  23(19–27)
Evaluation II score, median (interquartile range)
Length of intensive care unit stay (days)
Mean (range) 5.7(1.0–45.5)
Median (interquartile range) 2.6(1.6–6.6)
Admission causes
Cardiac 12
Respiratory 8
Infection 37
Trauma or surgery 12
Cardiac arrest 9
Other causes 5
Table 2
Vasoactive treatment, total maximal Sequential Organ Failure Assessment (TMS) score and hospital mortality, and their
association with outcome of the primary resuscitation
Vasoactive TMS score
n treatment n Nonsurvivors Mortality (%) (interquartile range)
Responders 52 Yes 41 12 29 10(7–12)
No 11 5 45 8(6–14)
Nonresponders 31 Yes 24 15 63b 13(10–16)a
No 7 1 14 8(6–14)
aP = 0.004, compared to responders with vasoactive treatment.
bSignificantly different from all other groups but ‘responders-no vasoactives’.R55
The mean arterial pressure at 24 hours after admission was
higher in responders than in nonresponders. The variables
measured with a pulmonary artery catheter were not associ-
ated with the resolution of perfusion failure (Table 3). The
oxygen delivery index did not differ between responders and
nonresponders. Infusions of crystalloids and colloids were
given in larger amounts to the nonresponders than to the
responders, respectively (Table 4). TMS scores of the non-
responders (12 [9–16]) were higher than those of the
responders (10 [7–12]) (P=0.019) (Fig. 1). The responders
had lower daily SOFA scores on day 1 (P=0.006), on day 2
(P<0.001) and on day 3 (P=0.001) than the nonrespon-
ders, but not later on. Because the presence of perfusion
failure defined as hyperlactatemia and/or base deficit was the
main grouping factor in the present study, we tried to elimi-
nate the contribution of circulatory failure to the TMS score.
This was accomplished by calculating the TMS score without
points of circulatory failure in order to assess the presence of
remote organ dysfunction. TMS scores without circulatory
failure were higher in nonresponders (9 [8–12]) than in
responders (8 [6–10]) (P=0.014).
The TMS scores of the nonsurvivors were higher (median, 13.0
[11–17]) than those of the survivors (8.0[7–12]) (P<0.001).
The hospital mortalities of patients with TMS score ≤5, with
TMS score=6–10, with TMS score=11–15 and with TMS
score >15 were 0%, 27%, 45% and 79%, respectively. The
TMS score without circulatory failure of the nonsurvivors (10
[9–13]) was higher than that of the survivors (7[6–9])
(P<0.001). The organ-specific components of the TMS score
were analysed separately. The points of coagulation (2[1–3]
versus 3[2–4], P=0.02), central nervous system (1[0–2]
versus 3[3–4], P<0.001), renal (1[0–2] versus 2[2–3],
P=0.04) and cardiovascular function (2[1–3] versus 3[3–4],
P=0.005) were different between survivors and nonsurvivors,
respectively. There were no differences in respiratory points
and in liver points between survivors and nonsurvivors.
Mortality increased with time from admission to peak TMS
(Fig.2). When the time to peak TMS was less than 3 days the
mortality was 28%, and when the time to peak TMS was
3–5 days the mortality was 47%. In patients with a time to
peak TMS longer than 5 days, only three out of 13 patients
were discharged alive from the hospital (mortality, 77%;
P=0.005 for a difference in mortality between groups of time to
Available online http://ccforum.com/content/7/4/R52
Table 3
Hemodynamic parameters in responders and nonresponders
of the resuscitation of acute circulatory failure
Responders Nonresponders
Cardiac Interquartile Interquartile
Index Median range Median range
Initial 3.3 2.3–3.8 2.8 2.1–4.5
Maximum 4.1 3.2–5.0 4.3 3.3–5.9
24 hours 3.2 2.5–4.2 3.3 2.5–4.6
Pulmonary arterial occlusion pressurea
Initial 10 8–14 10 7–13
Maximum 11 8–13 10 9–13
24 hours 10 7–14 9 7–12
Oxygen delivery index
Initial 424 303–564 410 316–590
Maximum 564 427–676 600 413–849
24 hours 439 343–548 442 335–666
Mean arterial pressurea
Initial 72 60–81 66 58–85
Maximum 75 65–84 72 67–83
24 hours 76* 66–86 65 62–78
aMaximum measured at the maximal cardiac index.
*Responders compared with nonresponders, P=0.005 (Mann–Whitney
U test).
Table 4
Fluid therapy in responders and nonresponders of the early resuscitation and in hospital survivors and nonsurvivors, respectively
Crystalloids Colloids Blood products (ml)
Resuscitation
Responders 1489 (383–2992) 475 (202–950) 192 (0–963)
Nonresponders 3254 (1300–7096) 950 (475–1900) 350 (0–1650)
P value 0.006 0.001 Not significant
Outcome
Survived 1502±267–3084 475±237–950 350±0–700
Died 3000±1284–5573 950±475–1425 350±0–1675
P value 0.009 0.008 Not significant
Values presented as median (interquartile range) or mean±standard deviation. P values refer to the Mann–Whitney U test.R56
peak TMS). Daily SOFA scores of the nonsurvivors were higher
than the scores of the survivors on day 1 (P<0.001), on day 2
(P>0.001) and on day 3 (P=0.001). Later on there was no dif-
ference in SOFA scores between survivors and nonsurvivors.
Discussion
We found that persisting tissue perfusion failure after treatment
of 24 hours was associated with more severe MOF compared
with resolved failure. However, the hemodynamic pattern,
except for mean arterial pressure 24 hours after admission, did
not differ between responders and nonresponders. The time
from admission to peak TMS was associated with the overall
prognosis, and a late peak TMS was associated with high mor-
tality. The pattern of daily SOFA scores differed between
responders and nonresponders as well as between survivors
and nonsurvivors during the first 3 days of ICU care.
Increased blood lactate concentrations in hypovolemic and
cardiogenic shock reflect anerobic metabolism due to hypo-
perfusion, but the interpretation of blood lactate concentra-
tions in septic patients is more complicated. A number of
studies have demonstrated that increased lactate concentra-
tion may result from cellular metabolic changes rather than
from global hypoperfusion, and that increasing systemic
oxygen delivery fails to normalise increased lactate concentra-
tions in septic patients [29]. Dissociation of lactate production
from oxygen transport has further been demonstrated in septic
shock patients [30]. Lactate values of the survivors decreased
but the value remained unchanged in nonsurvivors with cate-
cholamine treatment in 24 hours. The oxygen transport pattern
of the survivors did not differ from the nonsurvivors.
Increased oxygen delivery should be accompanied with
increased oxygen consumption, and a failure to increase
oxygen consumption with augmented oxygen delivery has
been shown to be a sign of poor prognosis in sepsis patients
[31]. Unfortunately, we have insufficient data on oxygen con-
sumption measured with an independent method to analyse
this in detail. In our study, 24% of patients were septic. The
hemodynamics of septic patients did not differ from those
without sepsis (data not presented). Increased lactate con-
centration and metabolic acidosis have been shown to be
sensitive but unspecific clinical signs of general tissue perfu-
sion failure despite the cause. Elevated arterial lactate without
metabolic acidosis for longer than 6 hours in general ICU
patients is associated with increased mortality [32]. Pro-
longed hyperlactatemia for longer than 24 hours is associ-
ated with increased mortality in trauma patients [14].
Prolonged lactic acidosis for longer than 24 hours is also
associated with development of organ failures and MOF [15].
Our results support the finding that prolonged tissue perfu-
sion failure, assessed by hyperlactatemia and metabolic aci-
dosis, is associated with the development of more severe
organ dysfunction and death. Except for mean arterial pres-
sure, neither hemodynamic variables nor oxygen delivery dif-
fered between responders and nonresponders. Our results
are in agreement with the study by Bernardin and colleagues
[33] showing that mean arterial pressure and lactate level
24 hours after the onset of treatment for septic shock were
the best early indicators of survival. Both an increased arterial
lactate level and an increased carbon dioxide gap, assessed
by gastric tonometry, at 24 hours after admission were
recently shown to predict increased mortality in mechanically
ventilated patients [34].
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Figure 1
Total maximal Sequential Organ Failure Assessment (TMS) scores in
relation to resuscitation outcome and in patients with intensive care
unit length of stay (ICU-LOS) shorter or longer than 2 days,
respectively. P value refers to the Mann–Whitney U test.
Kruskal–Wallis test for a difference between groups, P<0.001.
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Figure 2
The impact of the time to reach the peak total maximal Sequential
Organ Failure Assessment (TMS) on the hospital mortality. P=0.005
for a difference in mortality between groups, chi square-test.
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The nonresponders received more fluids than the responders
in the resuscitation phase in the present study, and still both
groups were treated to the same level of filling pressures.
Other studies have shown that the amount of fluids and blood
infused is a surrogate marker of the severity of illness and
injury. More severe acute illness may also lead to increased
capillary permeability and to increased fluid demand to reach
the same increase in vascular volume. Seven nonresponders
received only fluid resuscitation due to hypovolemia at admis-
sion. The mortality of these patients was low, suggesting that
the prognosis of patients with prolonged hyperlactatemia
caused by marked hypovolemia is good and does not neces-
sitate vasoactive intervention.
It has been shown that mortality of patients who can, as
opposed to those who cannot, maintain a high level of oxygen
delivery, self-generated or as a result of treatment, is lower
[4,35]. We were unable to find any association between
outcome and oxygen delivery. The results of a recent meta-
analysis demonstrated that early optimisation of hemodynam-
ics aiming to target goals reduced mortality in severely ill
patients [13]. Rivers and colleagues [36] showed that septic
shock patients treated to target values of central venous pres-
sure, mean arterial pressure and mixed venous saturation with
fluid loading and inotropes for at least 6 hours before ICU
admission resulted in decreased hospital mortality. During ICU
care, the protocol patients needed less fluids, blood and vaso-
pressors. The treatment before ICU admission can thus influ-
ence both the treatment in the ICU and also the outcome. In
our retrospective study, we could not demonstrate a beneficial
effect of high oxygen delivery on the outcome. We demon-
strated a correlation between mean arterial pressure and
resuscitation response that is in accordance with the study by
Rivers and colleagues. Our results demonstrate that early res-
olution of increased lactate concentration and acidosis is
associated with less severe MOF and with reduced mortality,
even though no differences in oxygen delivery could be found.
There are several alternatives for the definition of and grading
of the severity of MOF [22]. For this study we used SOFA
scoring [23]. The use of the daily SOFA score has been chal-
lenged, because daily evaluation can lead to underestimation
of the cumulative failures [25]. In contrast to daily maximal
SOFA scores, the calculation of the TMS score sums the
maximal scores of all organ failures during the whole ICU stay
independent of their time sequence. It thus quantifies the
severity of organ failures and their combinations into one
figure. The TMS score has been proved to be a fairly good
discriminator between survivors and nonsurvivors [24].
Our results demonstrated that mortality was high if the TMS
score at any time was greater than 15. On the contrary, if the
time between admission and the time to the peak TMS score
was longer than 5 days, mortality was also high. This suggests
that circulatory failure leading to the development of severe
multiple organ dysfunction with new organ systems involved,
or amplification of the failures already present after treatment
for 5 days, has a poor prognosis. Daily SOFA scores differed
between survivors and nonsurvivors on ICU days 1–3. It is
obvious that TMS scores and daily SOFA scores reflect differ-
ent aspects of the same phenomenon. Some organ failures
improve rapidly and are no longer counting towards the daily
SOFA scores. However, all new or worsening organ failures
add to the TMS score. In our study, TMS scores of both sur-
vivors and nonsurvivors were comparable with the multicenter
study by Moreno and colleagues [25]. Also, the overall mortal-
ity in our patients with different TMS categories was compara-
ble, even if only ICU mortality was reported in the study of
Moreno and colleagues. In contrast to patients with cardiovas-
cular and pulmonary diseases in the study by Janssens and
colleagues [24], the TMS scores of survivors and nonsurvivors
were remarkably lower. Our results are not biased with our
definition of circulatory failure because the TMS without circu-
latory failure showed exactly the same result.
The present study has limitations. The study consisted of a ret-
rospectively collected group of patients although the selection
criteria were fixed a priori. The strength of the study is that the
reconstruction of the hemodynamic profiles is precise, because
all continuously measured variables are stored as 2-min median
values in the computerised data management system. The
patients we studied were selected from all consecutive admit-
ted emergency patients who were treated in our ICU during a
1-year period. Hyperlactatemia can also result from confound-
ing factors. Sympathomimetic medication can cause lactate
elevations [20]. None of our patients had epinephrine infusion.
None of the patients had proven severe liver failure but one
patient had a pre-existing fat liver. One patient had a 4-hour
dialysis and his metabolic acidosis was corrected during the
first 24 hours of ICU care. Four patients had diabetes.
In conclusion, during the first 24 hours after admission, only
the mean arterial pressure was associated with the resolution
of acute tissue perfusion failure. The mean arterial pressure at
24 hours was higher in responders than in nonresponders.
Successful resuscitation of tissue perfusion failure was asso-
ciated with less severe MOF. The TMS score reflects well the
development of MOF, and the time pattern of the TMS score
is associated with overall mortality.
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Key messages
• Except for mean arterial pressure at 24 hours, 
successful resuscitation of ACF is not associated with
any invasively derived hemodynamic profile
• Successful resuscitation of ACF is associated with
less severe organ failure as assessed by TMS scores
and with lower mortality
• Late worsening of MOF as described by late TMS-
score accumulation is associated with high mortalityR58
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